{"id":44669,"date":"2022-06-03T16:01:34","date_gmt":"2022-06-03T14:01:34","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/ltc-senior-management-to-participate-in-the-nareit-reitweek-2022-conference\/"},"modified":"2022-06-03T16:01:34","modified_gmt":"2022-06-03T14:01:34","slug":"ltc-senior-management-to-participate-in-the-nareit-reitweek-2022-conference","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/ltc-senior-management-to-participate-in-the-nareit-reitweek-2022-conference\/","title":{"rendered":"LTC Senior Management to Participate in the NAREIT REITWeek 2022 Conference"},"content":{"rendered":"
\n

WESTLAKE VILLAGE, Calif.–(BUSINESS WIRE)–LTC Properties Inc. (NYSE: LTC), a real estate investment trust that invests in seniors housing and health care properties, today announced that senior management will participate in the NAREIT REITWeek 2022 Investor Conference on Tuesday, June 7 through Thursday June 9, 2022 in New York.\n<\/p>\n

<\/a><\/p>\n

\nThe Company\u2019s presentation package will be available online at https:\/\/ir.ltcreit.com\/Investors<\/a>.\n<\/p>\n

\nAbout LTC Properties<\/b>\n<\/p>\n

\nLTC is a real estate investment trust (REIT) investing in seniors housing and health care properties primarily through sale-leasebacks, mortgage financing, joint-ventures and structured finance solutions, including preferred equity and mezzanine lending. LTC\u2019s investment portfolio includes 202 properties in 29 states with 33 operating partners consisting of real property investments, first mortgages, mezzanine loans, working capital notes and unconsolidated joint ventures. Based on its gross investments, LTC\u2019s investment portfolio is comprised of approximately 50% seniors housing and 50% skilled nursing properties. Learn more at www.LTCreit.com<\/a>.\n<\/p>\n

\nForward Looking Statements<\/b>\n<\/p>\n

\nThis press release includes statements that are not purely historical and are \u201cforward looking statements\u201d within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements regarding the Company\u2019s expectations, beliefs, intentions or strategies regarding the future. All statements other than historical facts contained in this press release are forward looking statements. These forward looking statements involve a number of risks and uncertainties. Please see LTC\u2019s most recent Annual Report on Form 10-K, its subsequent Quarterly Reports on Form 10-Q, and its other publicly available filings with the Securities and Exchange Commission for a discussion of these and other risks and uncertainties. All forward looking statements included in this press release are based on information available to the Company on the date hereof, and LTC assumes no obligation to update such forward looking statements. Although the Company\u2019s management believes that the assumptions and expectations reflected in such forward looking statements are reasonable, no assurance can be given that such expectations will prove to have been correct. The actual results achieved by the Company may differ materially from any forward-looking statements due to the risks and uncertainties of such statements.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nWendy L. Simpson
\n
Pam Kessler
\n
(805) 981-8655\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

WESTLAKE VILLAGE, Calif.–(BUSINESS WIRE)–LTC Properties Inc. (NYSE: LTC), a real estate investment trust that invests in seniors housing and health care properties, today announced that senior management will participate in the NAREIT REITWeek 2022 Investor Conference on Tuesday, June 7 through Thursday June 9, 2022 in New York. The Company\u2019s presentation package will be available … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-44669","6":"format-standard","7":"category-industry"},"yoast_head":"\nLTC Senior Management to Participate in the NAREIT REITWeek 2022 Conference - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/ltc-senior-management-to-participate-in-the-nareit-reitweek-2022-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"LTC Senior Management to Participate in the NAREIT REITWeek 2022 Conference - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"WESTLAKE VILLAGE, Calif.–(BUSINESS WIRE)–LTC Properties Inc. (NYSE: LTC), a real estate investment trust that invests in seniors housing and health care properties, today announced that senior management will participate in the NAREIT REITWeek 2022 Investor Conference on Tuesday, June 7 through Thursday June 9, 2022 in New York. The Company\u2019s presentation package will be available ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/ltc-senior-management-to-participate-in-the-nareit-reitweek-2022-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-03T14:01:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220603005108\/en\/434356\/21\/LTC-REIT-Logo%28Larger_than_1_inch%29_smaller_reit.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ltc-senior-management-to-participate-in-the-nareit-reitweek-2022-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ltc-senior-management-to-participate-in-the-nareit-reitweek-2022-conference\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"LTC Senior Management to Participate in the NAREIT REITWeek 2022 Conference\",\"datePublished\":\"2022-06-03T14:01:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ltc-senior-management-to-participate-in-the-nareit-reitweek-2022-conference\\\/\"},\"wordCount\":376,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ltc-senior-management-to-participate-in-the-nareit-reitweek-2022-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220603005108\\\/en\\\/434356\\\/21\\\/LTC-REIT-Logo%28Larger_than_1_inch%29_smaller_reit.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ltc-senior-management-to-participate-in-the-nareit-reitweek-2022-conference\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ltc-senior-management-to-participate-in-the-nareit-reitweek-2022-conference\\\/\",\"name\":\"LTC Senior Management to Participate in the NAREIT REITWeek 2022 Conference - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ltc-senior-management-to-participate-in-the-nareit-reitweek-2022-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ltc-senior-management-to-participate-in-the-nareit-reitweek-2022-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220603005108\\\/en\\\/434356\\\/21\\\/LTC-REIT-Logo%28Larger_than_1_inch%29_smaller_reit.jpg\",\"datePublished\":\"2022-06-03T14:01:34+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ltc-senior-management-to-participate-in-the-nareit-reitweek-2022-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ltc-senior-management-to-participate-in-the-nareit-reitweek-2022-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ltc-senior-management-to-participate-in-the-nareit-reitweek-2022-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220603005108\\\/en\\\/434356\\\/21\\\/LTC-REIT-Logo%28Larger_than_1_inch%29_smaller_reit.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220603005108\\\/en\\\/434356\\\/21\\\/LTC-REIT-Logo%28Larger_than_1_inch%29_smaller_reit.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ltc-senior-management-to-participate-in-the-nareit-reitweek-2022-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"LTC Senior Management to Participate in the NAREIT REITWeek 2022 Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"LTC Senior Management to Participate in the NAREIT REITWeek 2022 Conference - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/ltc-senior-management-to-participate-in-the-nareit-reitweek-2022-conference\/","og_locale":"en_US","og_type":"article","og_title":"LTC Senior Management to Participate in the NAREIT REITWeek 2022 Conference - Pharma Trend","og_description":"WESTLAKE VILLAGE, Calif.–(BUSINESS WIRE)–LTC Properties Inc. (NYSE: LTC), a real estate investment trust that invests in seniors housing and health care properties, today announced that senior management will participate in the NAREIT REITWeek 2022 Investor Conference on Tuesday, June 7 through Thursday June 9, 2022 in New York. The Company\u2019s presentation package will be available ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/ltc-senior-management-to-participate-in-the-nareit-reitweek-2022-conference\/","og_site_name":"Pharma Trend","article_published_time":"2022-06-03T14:01:34+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220603005108\/en\/434356\/21\/LTC-REIT-Logo%28Larger_than_1_inch%29_smaller_reit.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/ltc-senior-management-to-participate-in-the-nareit-reitweek-2022-conference\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/ltc-senior-management-to-participate-in-the-nareit-reitweek-2022-conference\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"LTC Senior Management to Participate in the NAREIT REITWeek 2022 Conference","datePublished":"2022-06-03T14:01:34+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/ltc-senior-management-to-participate-in-the-nareit-reitweek-2022-conference\/"},"wordCount":376,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/ltc-senior-management-to-participate-in-the-nareit-reitweek-2022-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220603005108\/en\/434356\/21\/LTC-REIT-Logo%28Larger_than_1_inch%29_smaller_reit.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/ltc-senior-management-to-participate-in-the-nareit-reitweek-2022-conference\/","url":"https:\/\/pharma-trend.com\/en\/ltc-senior-management-to-participate-in-the-nareit-reitweek-2022-conference\/","name":"LTC Senior Management to Participate in the NAREIT REITWeek 2022 Conference - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/ltc-senior-management-to-participate-in-the-nareit-reitweek-2022-conference\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/ltc-senior-management-to-participate-in-the-nareit-reitweek-2022-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220603005108\/en\/434356\/21\/LTC-REIT-Logo%28Larger_than_1_inch%29_smaller_reit.jpg","datePublished":"2022-06-03T14:01:34+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/ltc-senior-management-to-participate-in-the-nareit-reitweek-2022-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/ltc-senior-management-to-participate-in-the-nareit-reitweek-2022-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/ltc-senior-management-to-participate-in-the-nareit-reitweek-2022-conference\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220603005108\/en\/434356\/21\/LTC-REIT-Logo%28Larger_than_1_inch%29_smaller_reit.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220603005108\/en\/434356\/21\/LTC-REIT-Logo%28Larger_than_1_inch%29_smaller_reit.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/ltc-senior-management-to-participate-in-the-nareit-reitweek-2022-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"LTC Senior Management to Participate in the NAREIT REITWeek 2022 Conference"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44669","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=44669"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44669\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=44669"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=44669"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=44669"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}